Percutaneous Neurostimulation in Knee Osteoarthritis

Tanta University100 enrolled

Overview

Peripheral nerve stimulation (PNS) is a drug-free pain management procedure that uses electrical impulses to target specific nerves and block pain signals. PNS helps decrease perception of pain, providing real answers to patients dealing with chronic knee pain. The case study discussed in this presentation is of the use of PNS targeting the superior lateral genicular nerve and the saphenous nerve for a patient with moderate to severe knee pain from osteoarthritis

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

100

Conditions

Osteoarthritis (OA) of the Knee Neuromodulation

Interventions

nerve stimulation using a nerve stimulator to the genicular nerveDEVICE

temporary transcutaneous nerve stimulation using a nerve stimulator to the genicular nerve, with settings 2Hz, 0.2mA, 1ms, where the nerve is stimulated for 4 to 6 minutes.

nerve stimulation using a nerve stimulator to the saphenous nerveDEVICE

temporary transcutaneous nerve stimulation using a nerve stimulator to the saphenous nerve, with settings 2Hz, 0.2mA, 1ms, where the nerve is stimulated for 4 to 6 minutes.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. adults between the ages of 30 and 70 years with a clinical diagnosis of moderate to severe knee OA who suffered knee pain. 2. Patients who cannot afford intra-articular injections or radiofrequency ablation (RFA). 3. patients who had failed 2 different oral pain medications and 6 weeks of physical therapy. Exclusion Criteria: 1. Patients with OA show improvement in pain after physiotherapy. 2. patients evaluated by an orthopaedic surgeon and deemed to be surgical candidates due to knee pathologies other than OA. 3. pregnant patients. 4. patients on anticoagulation therapy, who were not permitted to stop anticoagulation. 5. patients with previous trauma, neurological or endocrine diseases like diabetes mellitus, and knee tumors; and patients with inflammatory arthritis. 6. people who had received an intra-articular knee injection within the last 6 months. 7. Patients with tendon tears, bursitis, or calcified tendonitis as proven by imaging.

Locations (1)

Faculty of medicine, Tanta University

Tanta, Egypt

RECRUITING

Outcomes

Primary Outcomes

Change in visual analogue scale after intervention.

Decrement (clinical improvement) in visual analogue scale (VAS) immediately after intervention. The participant's knee discomfort was measured using a VAS. Participants were asked to score their level of pain on a 100-mm horizontal line, ranging from 0 to 100.

Time frame: immediately after intervention.

Central Contacts

Aliaa Mamdouh Abdelaziz Farag, MD

CONTACT

+201069468486 aliaa.mamdouh@med.tanta.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.